Search

everythinglearnresearchcommunity

for

Search:↓

FOXC1 is essential for keeping hair follicle stem cells inactive and maintaining their environment for healthy hair growth.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

AS101 reduces hair loss from chemotherapy.

17β-estradiol can reduce inflammation in the skin.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Increasing miR-149 reduces hair follicle stem cell growth and hair development by affecting certain cell growth pathways.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Blocking mTORC1 activity could increase hair pigmentation and potentially reverse greying.

FGF18 helps hair follicles resist radiation by stopping hair growth cycles.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.